Its akin to the ol' Einstein saying about insanity. "Doing the same thing over and over again and expecting different results." Apply that to AMDA, in regards to investors hoping it can sustain it's gains. Its going to take an FDA approval to make that happen. Many people will be making money when that happens.
The continued pain will be determined by the ER on Thursday. Pull up it's 2 year chart and look at the price action following the last ER's. Will this one be any different? That's just one thing traders will be focused on.
News 
Market Data 
Discover 
